Table 1.
Symptoms and health-related quality of life
| Total (n = 68) |
|
|---|---|
| Fatigue | 40 (59%) |
| Anxietya | |
| No | 36 (53%) |
| Mild | 8 (12%) |
| Moderate | 16 (24%) |
| Severe | 7 (10%) |
| Extremely | 0 |
| Depressiona | |
| No | 38 (56%) |
| Mild | 12 (18%) |
| Moderate | 15 (22%) |
| Severe | 2 (3%) |
| Extremely | 0 |
| Concentration problem | 34 (51%) |
| Dyspnoea mMRCb | |
| Grade 0 | 33 (48%) |
| Grade 1 | 15 (22%) |
| Grade 2 | 12 (18%) |
| Grade 3 | 5 (7%) |
| Grade 4 | 3 (4%) |
| Muscle or join ache | 27 (40%) |
| Sleep difficulties | 25 (37%) |
| Smell/taste disorders | 22 (32%) |
| Headache | 18 (26%) |
| Dry eyes or mouth | 18 (26%) |
| Hair loss | 17 (25%) |
| Chest pain | 10 (15%) |
| Cough | 10 (15%) |
| Diarrhoea | 8 (12%) |
| Palpitations | 6 (9%) |
| Dizziness | 6 (9%) |
| Sore throat | 4 (6%) |
| Fever/low grade fever | 0 |
| Persistent symptoms | |
| None | 7 (10%) |
| 1 or 2 | 13 (19%) |
| 3 or more | 48 (71%) |
| Patients who had not recovered their previous quality of life | 23 (34%) |
|
cEQ-5D-5L questionnaire (n = 23) | |
| Mobility: problems in walking about | |
| No problems | 11/23 (48%) |
| Slight problems | 8/23 (34%) |
| Moderate problems | 3/23 (13%) |
| Severe problems | 1/23 (4%) |
| Unable | 0 |
| Self-care: problems washing or dressing myself | |
| No problems | 21/23 (91%) |
| Slight problems | 2/23 (9%) |
| Moderate problems | 0 |
| Severe problems | 0 |
| Unable | 0 |
| Usual activities | |
| No problems | 3/23 (13%) |
| Slight problems | 10/23 (43%) |
| Moderate problems | 8/23 (35%) |
| Severe problems | 1/23 (4%) |
| Unable | 1/23 (4%) |
| Pain or discomfort | |
| No pain | 10/23 (43%) |
| Slight pain | 5/23 (22%) |
| Moderate pain | 6/23 (26%) |
| Severe pain | 2/23 (9%) |
| Extreme pain | 0 |
| Anxiety/depression | |
| Not anxious or depressed | 4/23 (17%) |
| Slightly anxious or depressed | 5/23 (22%) |
| Moderately anxious or depressed | 9/23 (39%) |
| Severely anxious or depressed | 5/23 (22%) |
| Extremely anxious or depressed | 0 |
| Patients with at least one persistent symptom 1 year after infection | 52 (76%) |
Data are expressed as n (%)
aAnxiety and depression were assessed using the Goldberg scale
bDyspnoea was categorized using the mMRC (modified British Medical Research Council)
cQuality of life was assessed by the EQ-5D-5L(EuroQol five-dimensions five-level questionnaire). The scale was performed on patients who reported not recovery of his previous quality of life (n = 23)